tiprankstipranks
Advertisement
Advertisement

GB:HEMO Stock Latest News

Hemogenyx Files Annual FDA IND Report as AML CAR‑T Trial Shows Early Promise
Company AnnouncementsHemogenyx Files Annual FDA IND Report as AML CAR‑T Trial Shows Early Promise
1d ago
Hemogenyx Advances HG-CT-1 CAR-T Program With Manufacturing Transfer and Trial Expansion
PremiumCompany Announcements
Hemogenyx Advances HG-CT-1 CAR-T Program With Manufacturing Transfer and Trial Expansion
15d ago
Hemogenyx Pharmaceuticals Updates Share Capital and Voting Rights Structure
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Updates Share Capital and Voting Rights Structure
2M ago
Hemogenyx Raises £118,632 Through Warrant Exercise and Expands Share Capital
PremiumCompany Announcements
Hemogenyx Raises £118,632 Through Warrant Exercise and Expands Share Capital
2M ago
Hemogenyx Raises £2.5m to Advance CAR-T Trials in Adult and Pediatric AML
PremiumCompany Announcements
Hemogenyx Raises £2.5m to Advance CAR-T Trials in Adult and Pediatric AML
2M ago
Hemogenyx Raises £2.5m to Advance AML CAR-T Trials and Reduce Costs
PremiumCompany AnnouncementsHemogenyx Raises £2.5m to Advance AML CAR-T Trials and Reduce Costs
2M ago
Hemogenyx Confirms Updated Share Capital and Voting Rights
Premium
Company Announcements
Hemogenyx Confirms Updated Share Capital and Voting Rights
3M ago
Hemogenyx Sets Early January Date for Admission of New Shares
Premium
Company Announcements
Hemogenyx Sets Early January Date for Admission of New Shares
4M ago
Hemogenyx Pharmaceuticals Announces Equity Issuance and Operational Updates
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Announces Equity Issuance and Operational Updates
4M ago
Hemogenyx Pharmaceuticals Publishes Prospectus for New Share Admission
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Publishes Prospectus for New Share Admission
5M ago
Hemogenyx Pharmaceuticals Advances CAR-T Therapy Trial with DSMB Approval
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Advances CAR-T Therapy Trial with DSMB Approval
6M ago
Hemogenyx’s Phase 1 AML Study: A Potential Game-Changer?
PremiumCompany Announcements
Hemogenyx’s Phase 1 AML Study: A Potential Game-Changer?
6M ago
HEMO
Hemogenyx Pharmaceuticals Expands Clinical Trial to Include Pediatric Patients
PremiumCompany AnnouncementsHemogenyx Pharmaceuticals Expands Clinical Trial to Include Pediatric Patients
6M ago
Hemogenyx Pharmaceuticals Announces Total Voting Rights Update
Premium
Company Announcements
Hemogenyx Pharmaceuticals Announces Total Voting Rights Update
7M ago
Hemogenyx Pharmaceuticals Advances CAR-T Therapy Trials and Eyes Early Revenue
Premium
Company Announcements
Hemogenyx Pharmaceuticals Advances CAR-T Therapy Trials and Eyes Early Revenue
7M ago
Hemogenyx Pharmaceuticals Partners with Cellin Technologies for CAR-T Therapy Commercialization in Estonia
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Partners with Cellin Technologies for CAR-T Therapy Commercialization in Estonia
7M ago
Hemogenyx Pharmaceuticals Advances CAR-T Therapy Trial for AML
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Advances CAR-T Therapy Trial for AML
7M ago
Hemogenyx Pharmaceuticals to Present at Prestigious DCNY Summit
PremiumCompany Announcements
Hemogenyx Pharmaceuticals to Present at Prestigious DCNY Summit
7M ago
Hemogenyx Pharmaceuticals Announces Warrant Exercise and Equity Issue
PremiumCompany Announcements
Hemogenyx Pharmaceuticals Announces Warrant Exercise and Equity Issue
7M ago
Hemogenyx Pharmaceuticals Announces Warrant Exercise and Equity Issuance
PremiumCompany AnnouncementsHemogenyx Pharmaceuticals Announces Warrant Exercise and Equity Issuance
7M ago
Hemogenyx Pharmaceuticals Secures £620,000 for CAR-T Therapy Trial
Premium
Company Announcements
Hemogenyx Pharmaceuticals Secures £620,000 for CAR-T Therapy Trial
8M ago
Hemogenyx Pharmaceuticals to Re-Appoint PKF Littlejohn LLP as Auditor
Premium
Company Announcements
Hemogenyx Pharmaceuticals to Re-Appoint PKF Littlejohn LLP as Auditor
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >